FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157354484> ?p ?o ?g. }

• W3157354484 endingPage "2413" @default.
• W3157354484 startingPage "2404" @default.
• W3157354484 abstract "Recurrence of esophageal cancer (EC) after chemotherapy may mainly be explained by the existence of chemotherapy-resistant cells, and an effective drug against chemotherapy-resistant cells is highly sought. The aim of this study was to investigate the cytotoxicity of bispecific antibody solitomab combined with γ δ T cells on Eca109 cell spheres.We cultured Eca109 cell spheres in serum-free medium, and the morphological differences between wild-type Eca109 cells and Eca109 cell spheres were compared by microscope and flow cytometry. Different concentrations of nanoparticle albumin-bound paclitaxel (Nab-PTX) and cisplatin were used to treat the two groups of cells and compare their drug resistance. Flow cytometry was then used to detect the expression level of epithelial cell adhesion molecule (EpCAM) and the cytotoxicity of γ δ T cells combined with bispecific antibody solitomab on the two groups.Flow cytometry analysis showed that Eca109 cell spheres were smaller in size and had less cytoplasmic granules and CCK-8 assay showed that the viability of Eca109 cell spheres treated with different concentrations of Nab-PTX and cisplatin was significantly higher than that of wild-type Eca109 cells (P<0.05). Flow cytometry also showed that the expression level of EpCAM on Eca109 cell spheres was higher than that of wild-type Eca109 cells. Co-culture experiment showed that there was no significant difference in the cytotoxicity of γ δ T cells to wild-type Eca109 cells and Eca109 cell spheres without solitomab. However, after adding solitomab, the cytotoxicity of γ δ T cells to Eca109 cell spheres was significantly higher than that of wild-type Eca109 cells (P<0.05).EC Eca109 cell spheres have strong stem cell characteristics such as multidrug resistance and may contain a high proportion of EC stem cells. Further, EC Eca109 cell spheres have a high expression level of EpCAM, and EpCAM may be one of the markers of EC stem cells. Therefore, EpCAM could be used as a potential molecular target of immunotherapy for EC, and solitomab may become an effective immunotherapeutic drug for chemotherapy-resistant EC cells." @default.
• W3157354484 created "2021-05-10" @default.
• W3157354484 creator A5002586536 @default.
• W3157354484 creator A5013653434 @default.
• W3157354484 creator A5047928155 @default.
• W3157354484 creator A5054421262 @default.
• W3157354484 creator A5063481044 @default.
• W3157354484 creator A5079594267 @default.
• W3157354484 date "2021-04-01" @default.
• W3157354484 modified "2023-09-24" @default.
• W3157354484 title "EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab" @default.
• W3157354484 cites W1139320071 @default.
• W3157354484 cites W1589571763 @default.
• W3157354484 cites W1983770566 @default.
• W3157354484 cites W1988835634 @default.
• W3157354484 cites W1990261336 @default.
• W3157354484 cites W1993325062 @default.
• W3157354484 cites W1999356404 @default.
• W3157354484 cites W2007046259 @default.
• W3157354484 cites W2027232973 @default.
• W3157354484 cites W2029634531 @default.
• W3157354484 cites W2034668939 @default.
• W3157354484 cites W2078837657 @default.
• W3157354484 cites W2080765801 @default.
• W3157354484 cites W2083558581 @default.
• W3157354484 cites W2087962206 @default.
• W3157354484 cites W2118448242 @default.
• W3157354484 cites W2123509170 @default.
• W3157354484 cites W2147947369 @default.
• W3157354484 cites W2148960961 @default.
• W3157354484 cites W2153382986 @default.
• W3157354484 cites W2156381851 @default.
• W3157354484 cites W2158741313 @default.
• W3157354484 cites W2159405948 @default.
• W3157354484 cites W2167650288 @default.
• W3157354484 cites W2241789450 @default.
• W3157354484 cites W2343950992 @default.
• W3157354484 cites W2465250101 @default.
• W3157354484 cites W2490991344 @default.
• W3157354484 cites W2548355296 @default.
• W3157354484 cites W2602970936 @default.
• W3157354484 cites W2611197650 @default.
• W3157354484 cites W2617696599 @default.
• W3157354484 cites W2752476672 @default.
• W3157354484 cites W2777933299 @default.
• W3157354484 cites W2781850612 @default.
• W3157354484 cites W2886848040 @default.
• W3157354484 cites W2889646458 @default.
• W3157354484 cites W2901588705 @default.
• W3157354484 cites W2909663160 @default.
• W3157354484 cites W2917837889 @default.
• W3157354484 cites W2973762430 @default.
• W3157354484 cites W3027037341 @default.
• W3157354484 cites W4211048478 @default.
• W3157354484 cites W4249441028 @default.
• W3157354484 doi "https://doi.org/10.21037/jtd-21-442" @default.
• W3157354484 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8107559" @default.
• W3157354484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34012588" @default.
• W3157354484 hasPublicationYear "2021" @default.
• W3157354484 type Work @default.
• W3157354484 sameAs 3157354484 @default.
• W3157354484 citedByCount "1" @default.
• W3157354484 countsByYear W31573544842023 @default.
• W3157354484 crossrefType "journal-article" @default.
• W3157354484 hasAuthorship W3157354484A5002586536 @default.
• W3157354484 hasAuthorship W3157354484A5013653434 @default.
• W3157354484 hasAuthorship W3157354484A5047928155 @default.
• W3157354484 hasAuthorship W3157354484A5054421262 @default.
• W3157354484 hasAuthorship W3157354484A5063481044 @default.
• W3157354484 hasAuthorship W3157354484A5079594267 @default.
• W3157354484 hasBestOaLocation W31573544841 @default.
• W3157354484 hasConcept C109316439 @default.
• W3157354484 hasConcept C1491633281 @default.
• W3157354484 hasConcept C153911025 @default.
• W3157354484 hasConcept C159654299 @default.
• W3157354484 hasConcept C185592680 @default.
• W3157354484 hasConcept C202751555 @default.
• W3157354484 hasConcept C203014093 @default.
• W3157354484 hasConcept C2776677690 @default.
• W3157354484 hasConcept C553184892 @default.
• W3157354484 hasConcept C55493867 @default.
• W3157354484 hasConcept C86803240 @default.
• W3157354484 hasConceptScore W3157354484C109316439 @default.
• W3157354484 hasConceptScore W3157354484C1491633281 @default.
• W3157354484 hasConceptScore W3157354484C153911025 @default.
• W3157354484 hasConceptScore W3157354484C159654299 @default.
• W3157354484 hasConceptScore W3157354484C185592680 @default.
• W3157354484 hasConceptScore W3157354484C202751555 @default.
• W3157354484 hasConceptScore W3157354484C203014093 @default.
• W3157354484 hasConceptScore W3157354484C2776677690 @default.
• W3157354484 hasConceptScore W3157354484C553184892 @default.
• W3157354484 hasConceptScore W3157354484C55493867 @default.
• W3157354484 hasConceptScore W3157354484C86803240 @default.
• W3157354484 hasIssue "4" @default.
• W3157354484 hasLocation W31573544841 @default.
• W3157354484 hasLocation W31573544842 @default.
• W3157354484 hasLocation W31573544843 @default.
• W3157354484 hasOpenAccess W3157354484 @default.

• next